The use, misuse and abuse of dabigatran

被引：7
|
作者：
Attia, John R. [1 ]
Pearce, Robert [2 ]
机构：
[1] Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia
[2] John Hunter Hosp, Newcastle, NSW, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2013年 / 198卷 / 07期
关键词：
ATRIAL-FIBRILLATION; WARFARIN; THERAPY; STROKE; RISK;
D O I：
10.5694/mja12.10729
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [21] Is one month treatment with dabigatran before cardioversion of atrial fibrillation sufficient to prevent thromboembolism?
    Johansson, Anna-Karin
    Juhlin, Tord
    Engdahl, Johan
    Lind, Stefan
    Hagwall, Kristina
    Rorsman, Cecilia
    Fodor, Emoke
    Alenholt, Anna
    Nordin, Astrid Paul
    Rosenqvist, Marten
    Frick, Mats
    EUROPACE, 2015, 17 (10): : 1514 - 1517
  • [22] Dabigatran for stroke prevention in atrial fibrillation
    Hohnloser, S. H.
    Diener, H. -C.
    HAMOSTASEOLOGIE, 2012, 32 (03): : 216 - 220
  • [23] Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
    Correia Monteiro, Jean Michell
    San-Martin, Daniel Lordelo
    Gondim Silva, Beatriz Carneiro
    Barbosa Souza, Ian Felipe
    Oliveira Filho, Jamary
    Jesus, Pedro
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2019, 77 (02) : 80 - 83
  • [24] Mortality associated with the use of non-vitamin K antagonist oral anticoagulants in cancer patients: Dabigatran versus rivaroxaban
    Lin, Yu-Sheng
    Kuan, Feng-Che
    Chao, Tze-Fan
    Wu, Michael
    Chen, Shao-Wei
    Chen, Mien-Cheng
    Chung, Chang-Ming
    Chu, Pao-Hsien
    Lip, Gregory Y. H.
    Wu, Victor Chien-Chia
    CANCER MEDICINE, 2021, 10 (20): : 7079 - 7088
  • [25] Dabigatran or warfarin for the prevention of stroke in atrial fibrillation? A closer look at the RE-LY trial
    DiNicolantonio, James J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (08) : 1101 - 1111
  • [26] Monitoring the use of dabigatran etexilate for stroke prevention: compliance with renal function guidelines
    Simpson, Bryan H.
    Reith, David M.
    Medlicott, Natalie J.
    Smith, Alesha J.
    JOURNAL OF PRIMARY HEALTH CARE, 2020, 12 (04) : 327 - 334
  • [27] Use of Dabigatran for Periprocedural Anticoagulation in Patients Undergoing Catheter Ablation for Atrial Fibrillation
    Bassiouny, Mohamed
    Saliba, Walid
    Rickard, John
    Shao, Mingyuan
    Sey, Albert
    Diab, Mariam
    Martin, David O.
    Hussein, Ayman
    Khoury, Maurice
    Abi-Saleh, Bernard
    Alam, Samir
    Sengupta, Jay
    Borek, P. Peter
    Baranowski, Bryan
    Niebauer, Mark
    Callahan, Thomas
    Varma, Niraj
    Chung, Mina
    Tchou, Patrick J.
    Kanj, Mohamed
    Dresing, Thomas
    Lindsay, Bruce D.
    Wazni, Oussama
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (03) : 460 - 466
  • [28] Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran
    Weimar, Christian
    Hohnloser, Stefan H.
    Eikelboom, John W.
    Diener, Hans-Christoph
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2012, 12 (01) : 17 - 23
  • [29] The trouble with dabigatran
    Charlton, Blake
    Redberg, Rita
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [30] Opioid Misuse/Abuse and Quality Persistent Pain Management in Older Adults
    Chang, Yu-Ping
    Compton, Peggy
    JOURNAL OF GERONTOLOGICAL NURSING, 2016, 42 (12): : 21 - 30
12345